Understanding CTD & eCTD for Pharmaceutical Market Registration
A complete guide to Common Technical Document (CTD) and electronic CTD (eCTD) structures, Module 1–5 organization, and international regulatory registration strategies.
Pharmaceutical products entering a new international market generally require regulatory documentation that allows the relevant authority to evaluate the product's quality, safety, and efficacy. One of the most widely used structures for presenting pharmaceutical registration information is the Common Technical Document (CTD). The electronic version of this structure, known as eCTD, provides a standardized digital format for submitting regulatory information to participating health authorities.
What Is a CTD?
The Common Technical Document is a standardized framework for organizing pharmaceutical registration information.
Instead of preparing completely different documentation structures for every market, the CTD provides a common framework that brings technical information together into defined modules.
The CTD is generally divided into five modules:
Module 1 — Administrative & Regional Information
This section contains information specific to the regulatory authority and market where the application is being submitted.
Depending on the country, this may include:
- Application forms
- Administrative documents
- Product information
- Manufacturing information
- Certificates
- Legal documents
- Country-specific declarations
Module 2 — Summaries
Module 2 provides structured summaries of the detailed technical information contained in the other modules.
The purpose is to help reviewers understand the overall scientific information without immediately reviewing every detailed study.
- Quality overall summary (QOS)
- Non-clinical overview
- Clinical overview
- Non-clinical summaries
- Clinical summaries
Module 3 — Quality
Module 3 focuses on the pharmaceutical quality of the product.
For generic pharmaceutical products, the quality section is particularly important because the authority needs sufficient information to evaluate consistency and product quality.
- Active pharmaceutical ingredient (API) information
- Manufacturing process
- Specifications
- Analytical methods
- Validation information
- Excipients
- Finished product manufacturing
- Finished product specifications
- Packaging components
- Stability data
Module 4 — Non-Clinical Study Reports
Module 4 contains applicable non-clinical information.
The exact requirements depend on the product type and applicable regulatory framework.
- Pharmacology
- Pharmacokinetics
- Toxicology
- Other relevant non-clinical studies
Module 5 — Clinical Study Reports
Module 5 contains clinical information supporting the application.
For many generic medicines, bioequivalence information plays an important role in demonstrating therapeutic equivalence to the reference product.
- Clinical study reports
- Bioequivalence studies
- Clinical pharmacology information
- Relevant literature
- Other clinical documentation
What Is eCTD?
eCTD is the electronic implementation of the CTD structure.
Instead of submitting a dossier as a collection of disconnected documents, eCTD organizes the information into a structured electronic submission.
- Standardized organization
- Easier regulatory review
- Structured document navigation
- Version management
- Lifecycle management
- Improved document traceability
CTD vs eCTD: Key Differences
The underlying technical structure can be similar, but the submission format and electronic management are different.
CTD: A standardized dossier structure for organizing regulatory information.
eCTD: An electronic submission format that manages the CTD information and its lifecycle digitally.
Why Dossier Quality Matters
A dossier is more than simply collecting documents. The information needs to be consistent, complete, traceable, properly formatted, scientifically supported, and appropriate for the target market.
Inconsistencies between product specifications, manufacturing information, certificates, packaging details, and other documents can create questions during regulatory review.
Preparing for an International Registration
Before beginning a registration project, companies should identify the target country, regulatory authority, product and dosage form, registration pathway, required documentation, manufacturing source, packaging requirements, stability requirements, API documentation, and local regulatory directives.
Requirements can vary significantly between markets, so a dossier should always be prepared according to the applicable authority's current requirements.
More Technical Regulatory Insights
WHO-GMP in Pharmaceutical Manufacturing: What Buyers Should Know
Essential insights into Good Manufacturing Practice (GMP), quality systems, analytical controls, documentation audits, and evaluating pharmaceutical manufacturing partners.
Choosing the Right Pharmaceutical Dosage Form
A technical evaluation of tablets, capsules, syrups, sachets, effervescent tablets, and topical preparations to select the optimal delivery system for commercial success.